Stock AnalizHumana (HUM) earnings for the quarter ended September 2026: EPS beats estimates
Humana reported results for the quarter ended September 2026 on November 6, 2026. Adjusted earnings per share came in at -$0.70 against the analysts’ average forecast of -$1.00, a beat of 30.3%.
Revenue for the quarter was $41.16 billion, up 26.1% from $32.65 billion in the same quarter a year earlier.
The market’s verdict: the stock rose 5.3% on the first trading day after the report.
The last four quarters
Humana has beaten the analysts’ EPS forecast in 4 of the last 4 quarters.
| Quarter | EPS | Forecast | Surprise | Revenue growth | Price reaction |
|---|---|---|---|---|---|
| Sep 2026 | -$0.70 | -$1.00 | +30.3% | +26% | +5.3% |
| Jun 2026 | $7.61 | $7.00 | +8.8% | — | −5.7% |
| Mar 2026 | $10.31 | $10.20 | +1.1% | +23% | +2.9% |
| Dec 2025 | -$3.96 | -$3.99 | +0.7% | +11% | −1.4% |
What comes next
Analysts expect EPS of -$7.55 for the next quarter on average and $9.52 for the fiscal year ending December 31, 2026.
The average analyst price target is $494.25, 10% above the current price of $450.00.
Valuation and score
Humana scores 2.4 out of 5 overall on Stock Analiz (average), trades at a trailing P/E of about 43.7, and its intrinsic value under moderate assumptions is about 15% above the current market value. Full Humana analysis with 10 years of financials
Frequently asked questions
What was Humana’s EPS for the quarter ended September 2026?
-$0.70 adjusted per share, against an analyst consensus of -$1.00.
How much revenue did Humana report?
$41.16 billion, up 26.1% year over year.
More
This report was written automatically from the published numbers within hours of the release. It is information, not investment advice.